Location History:
- Paris, FR (2018)
- Alfortville, FR (2013 - 2019)
Company Filing History:
3 out of 5,076 
2 out of 67 
1 out of 1,743 
Years Active: 2013-2019
Title: The Innovations of Peter Vanhoutte
Introduction
Peter Vanhoutte is a notable inventor based in Alfortville, France. He has made significant contributions to the field of biotechnology, particularly in the development of peptides that serve as inhibitors in various cellular pathways. With a total of 3 patents, Vanhoutte's work has implications for cancer treatment and cellular regulation.
Latest Patents
One of his latest patents is titled "Inhibitor Peptides of ERK-type MAP kinase." This invention concerns peptides that are useful as MAP kinase/ERK pathway-specific inhibitors relative to a given substrate in a specific subcellular compartment. Another significant patent is "Selective Inhibitors of c-Fos and Their Antiproliferative Properties." This invention relates to selective inhibitors of c-Fos for use in the prevention and/or treatment of cancers and restenosis.
Career Highlights
Throughout his career, Peter Vanhoutte has worked with esteemed institutions such as the Centre National de la Recherche Scientifique and Université Pierre et Marie Curie. His research has focused on understanding cellular mechanisms and developing innovative solutions to combat diseases.
Collaborations
Peter has collaborated with notable colleagues in his field, including Jocelyne Caboche and Eleni Tzavara. Their combined expertise has contributed to advancements in the understanding of cellular pathways and therapeutic interventions.
Conclusion
Peter Vanhoutte's innovative work in the field of biotechnology highlights the importance of research in developing targeted therapies for complex diseases. His contributions continue to influence the scientific community and pave the way for future advancements.